AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq (upadacitinib; 15mg once ...
Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms ...
Regeneron has announced new results from the phase 2 COURAGE trial evaluating trevogrumab (anti-GDF8/anti-myostatin) for its ...
Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results